Effect of TEI-6720, a xanthine oxidase inhibitor, on the nucleoside transport in the lung cancer cell line A549

Pharmacology

Volumn 60, Issue 1, 2000, Pages 34-40

  Yamamoto, Tetsuya ^a   Moriwaki, Yuji ^a   Fujimura, Yoshihiro ^b   Takahashi, Sumio ^a   Tsutsumi, Zenta ^a   Tsutsui, Takahiko ^a   Higashino, Kazuya ^a   Hada, Toshikazu ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Inosine; Nucleoside transport; Uridine; Xanthine oxidase

Indexed keywords

ADENINE PHOSPHORIBOSYLTRANSFERASE; ADENOSINE DEAMINASE; FEBUXOSTAT; GUANINE DEAMINASE; HYPOXANTHINE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; INOSINE; PURINE; PURINE NUCLEOSIDE PHOSPHORYLASE; PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE; UNCLASSIFIED DRUG; URACIL; URIDINE; XANTHINE; XANTHINE OXIDASE; XANTHINE OXIDASE INHIBITOR;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LUNG CANCER; NUCLEOSIDE TRANSPORT; PRIORITY JOURNAL; PURINE METABOLISM;

EID: 0033985499     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000028344     Document Type: Article

References (16)

1. Osada Y, Tsuchimoto M, Fukushima H, Takahashi K, Kondo S, Hasegawa M, Komoriya K: Hypouricemic effect of the novel xanthine oxidase inhibitor, TEI-6720, in rodents. Eur J Pharmacol 1993;241:183-188.
2. Komoriya K, Osada Y, Hasegawa M, Horiuchi H, Kondo S, Couch RC, Griffin TB: Hypouricemic effect of allopurinol and the novel xanthine oxidase inhibitor TEI-6720 in chimpanzees. Eur J Pharmacol 1993;250:455-460.
3. Giard DJ, Aaronson AS, Todaro GJ, Arnstein P, Kersey JH, Dosik H, Parks WP: In vitro cultivation of human tumors: Establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 1973;51:1417-1423.
4. 1 epithelia. Biochem Biophys Acta 1992;1106:303-310.
5. Yamamoto T, Moriwaki Y, Agbedana OE, Takahashi S, Suda M, Higashino K: Oxypurine metabolism of xanthine oxidase-deficient hepatoma-derived cell line HuH-7: Effect of exogenous purines and allopurinol. Horm Metab Res 1994;26:389-392.
6. Yamamoto T, Moriwaki Y, Takahashi S, Zennta T, Yamakita J, Hiroishi K, Higashino K: Determination of human plasma xanthine oxidase activity by high-performance liquid chromatography. J Chromatogr B Biomed Appl 1996;681:395-400.
7. Sakuma R, Nishina T, Kitamura M, Yamanaka H, Kamatani N, Nishioka K: Screening for adenine and hypoxanthine phosphoribosyl transferase deficiencies in human erythrocytes by high-performance liquid chromatography. Clin Chim Acta 1987;170:281-290.
8. Willson JK, Fischer PH, Remick SC, Tutsch KD, Grem JL, Nieting L, Alberti D, Bruggink J. Trump DL: Methotrexate and dipyridamole combination chemotherapy based upon inhibition of nucleoside salvage in humans. Cancer Res 1989;49:1866-1870.
9. Zhen Y-S, Lui MS, Weber G: Effects of acivicin and dipyridamole on hepatoma 3924A cells. Cancer Res 1983;43:1616-1619.
10. Gan XT, Cook MA, Moffat MP, Karmazyn M: Transient ischemia in the presence of an adenosine deaminase plus a nucleoside transport inhibitor confers protection against contractile depression produced by hydrogen peroxide: Possible role of glycogen. J Mol Cell Cardiol 1996;28:1165-1176.
11. Fremes SE, Furukawa RD, Zhang J, Li R-K, Tsumiati LC, Weisel RD, Mickle DAG: Cardiac storage with University of Wisconsin solution and a nucleoside-transport blocker. Ann Thorac Surg 1995;59:1127-1133.
12. Howell S, Horn DK, Sanga R, Vick JS, Chan TCK: Dipyridamole enhancement of etoposide sensitivity. Cancer Res 1989;49:4147-4153.
13. Belle HV, Verheyen W, Donck KV, Janssen PAJ, Robertson JIS: Prevention of catecholamine-induced cardiac damage and death with a nucleoside transport inhibitor. J Cardiovasc Pharmacol 1992;20:173-178.
14. Werns SW, Shea MJ, Mitsos SE, Dysko RC, Fantone JC, Schork MA, Abrams GD, Pitt B, Lucchesi BR: Reduction of the size of infarction by allopurinol in the ischemic-reperfused canine heart. Circulation 1986;73:518-524.
15. Chambers DE, Parks DA, Patterson G, Roy R, McCord JM, Yoshida S, Parmley LF, Downey JM: Xanthine oxidase as a source of free radical damage in myocardial ischemia. J Mol Cell Cardiol 1985;17:145-152.
16. Werns SW, Lucchesi BR: Myocardial ischemia and reperfusion: The role of oxygen radicals in tissue injury. Cardiovasc Drugs Ther 1989;2: 761-769.